Inhibikase Therapeutics, Inc. · NASDAQ:IKT

ADAR1 Capital Management, LLC reported a 9.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

ADAR1 Capital Management, LLC reported a 9.90% stake in Inhibikase Therapeutics, Inc., 12,523,371 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
12,523,371
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC9.90%12,523,371
ADAR1 Capital Management GP, LLC9.90%12,692,387
Daniel Schneeberger9.90%12,523,371

Source

View original at SEC

Related